Covetrus, Inc.
CVET · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $1,217 | $1,148 | $1,122 | $1,162 |
| % Growth | 6% | 2.3% | -3.4% | – |
| Cost of Goods Sold | $988 | $923 | $910 | $946 |
| Gross Profit | $229 | $225 | $212 | $216 |
| % Margin | 18.8% | 19.6% | 18.9% | 18.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $225 | $219 | $219 | $220 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $225 | $219 | $219 | $220 |
| Operating Income | $4 | $8 | -$4 | -$4 |
| % Margin | 0.3% | 0.7% | -0.4% | -0.3% |
| Other Income/Exp. Net | -$7 | -$7 | -$6 | -$10 |
| Pre-Tax Income | -$3 | $1 | -$10 | -$14 |
| Tax Expense | $1 | $3 | -$7 | -$10 |
| Net Income | -$4 | -$2 | -$3 | -$4 |
| % Margin | -0.3% | -0.2% | -0.3% | -0.3% |
| EPS | -0.029 | -0.015 | -0.022 | -0.029 |
| % Growth | -97.2% | 33.2% | 25.7% | – |
| EPS Diluted | -0.029 | -0.015 | -0.022 | -0.029 |
| Weighted Avg Shares Out | 140 | 138 | 138 | 137 |
| Weighted Avg Shares Out Dil | 140 | 138 | 138 | 137 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $7 | $7 | $6 | $8 |
| Depreciation & Amortization | $48 | $48 | $51 | $49 |
| EBITDA | $52 | $58 | $50 | $43 |
| % Margin | 4.3% | 5.1% | 4.5% | 3.7% |